Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease
Chemical Biology & Drug Design · 2024-02 · 103 (2)
DOI: 10.1111/cbdd.14482 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 20.02.2024. Verfasst von Efe Doğukan Dincel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Istanbul University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Carbonic Anhydrases, Alzheimer Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Istanbul Üniversitesi.
Themen: Demenz
Abstract (Originalsprache)
In this project, non‐sulfonamide bistrifluoromethyl‐derived hydrazide‐hydrazones were synthesized as multi‐target‐directed ligands to treat Alzheimer's disease and then, the novel derivatives were characterized by diverse spectral methods. Acetylcholinesterase (AChE), and human carbonic anhydrase (hCA) inhibitory qualifications of these compounds were determined. The reported compounds ( 2a ‐ y ) were determined to be effective inhibitors of the hCA I, hCA II and AChE enzymes with K i values in the range of 1.130 ± 0.15–5.440 ± 0.93 μM for hCA I, 0.894 ± 0.05–6.647 ± 1.35 μM for hCA II, and 0.196 ± 0.03–4.222 ± 1.04 μM for AChE. In silico studies were also performed to illuminate the binding interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Istanbul University, Istanbul, Turkey.
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, European University of Lefke, Mersin, Turkey.
- Faculty of Science, Department of Chemistry, Atatürk University, Erzurum, Turkey.
ORCID-Profile: Efe Doğukan Dincel, Faika Başoğlu-Ünal
Förderung
- Istanbul Üniversitesi
Zitieren
APA
Dincel, E. D., Başoğlu-Ünal, F., Kuran, E. D., Kayra, T., Aydın, N., Kanber, E., Gülçin, İ., & Ulusoy-Güzeldemirci, N. (2024). Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease. Chemical Biology & Drug Design, 103(2). https://doi.org/10.1111/cbdd.14482
Vancouver
Dincel ED, Başoğlu-Ünal F, Kuran ED, Kayra T, Aydın N, Kanber E, et al. Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease. Chemical Biology & Drug Design. 2024;103(2). doi:10.1111/cbdd.14482
BibTeX
@article{Dincel2024,
author = {Dincel, Efe Doğukan and Başoğlu-Ünal, Faika and Kuran, Ebru Didem and Kayra, Tülay and Aydın, Nurcan and Kanber, Esmanur and Gülçin, İlhami and Ulusoy-Güzeldemirci, Nuray},
title = {Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease},
journal = {Chemical Biology & Drug Design},
year = {2024},
volume = {103},
number = {2},
doi = {10.1111/cbdd.14482}
}
EUVIMED